Patents by Inventor Martin Leeb

Martin Leeb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250170273
    Abstract: The present invention relates to therapeutic proteins (therapeutic proteins) for use in the treatment of polyQ diseases by therapy, mRNAs, gene therapy vectors or viral particles coding for said therapeutic proteins and composition comprising them.
    Type: Application
    Filed: February 9, 2023
    Publication date: May 29, 2025
    Applicants: UNIVERSITA' DEGLI STUDI DI PADOVA (95%), UNIVERSITÄT WIEN (5%)
    Inventors: Graziano Martello, Giorgia Maria Ferlazzo, Anna Maria Gambetta, Martin Leeb
  • Patent number: 11085020
    Abstract: The invention relates to mammalian haploid embryonic stem cells and methods for the production of such stem cells. The inventions also relates to a cell culture and a cell line of mammalian haploid embryonic stem cells.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: August 10, 2021
    Inventors: Anton Wutz, Martin Leeb
  • Publication number: 20180273902
    Abstract: The invention relates to mammalian haploid embryonic stem cells and methods for the production of such stem cells. The inventions also relates to a cell culture and a cell line of mammalian haploid embryonic stem cells.
    Type: Application
    Filed: March 20, 2018
    Publication date: September 27, 2018
    Inventors: Anton WUTZ, Martin LEEB
  • Patent number: 9957479
    Abstract: The invention relates to mammalian haploid embryonic stem cells and methods for the production of such stem cells. The inventions also relates to a cell culture and a cell line of mammalian haploid embryonic stem cells.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: May 1, 2018
    Inventors: Anton Wutz, Martin Leeb
  • Publication number: 20140057801
    Abstract: The invention relates to mammalian haploid embryonic stem cells and methods for the production of such stem cells. The inventions also relates to a cell culture and a cell line of mammalian haploid embryonic stem cells.
    Type: Application
    Filed: March 2, 2012
    Publication date: February 27, 2014
    Applicant: CAMBRIDGE ENTERPRISE LIMITED
    Inventors: Anton Wutz, Martin Leeb